NeuBase Therapeutics, Inc.

NBSENASDAQHealthcare

$0.38

$-0.01(-1.56%)

Market Cap$1418101

P/E Ratio—

52W High$4.44

52W Low$0.36

Avg Volume127K

Open$0.38

Beta0.94

Employees Ownership Insider Trades

NeuBase Therapeutics, Inc. (NBSE) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NBSE · as of Dec 21, 2022

Latest filing snapshot

+4+12.12%vs prior year

NeuBase Therapeutics, Inc. (NBSE) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2022-09-30·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+12.12%

Revenue / Employee

—

Net Income / Employee

$-925.3K

Market Cap

$1M

NBSE Employee Count

2008 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2022-12-21	2022-09-30	37	+4	+12.12%
2021-12-23	2021-09-30	33	+18	+120.00%
2020-12-23	2020-09-30	15	+6	+66.67%
2020-01-10	2019-09-30	9	+6	+200.00%
2019-01-03	2018-09-30	3	-1	-25.00%
2017-12-15	2017-09-30	4	-10	-71.43%
2016-12-22	2016-09-30	14	-2	-12.50%
2015-12-14	2015-09-30	16	+3	+23.08%
2014-12-22	2014-09-30	13	+11	+550.00%
2013-12-27	2013-09-30	2	+0	+0.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IMPL

Impel Pharmaceuticals Inc.

160$1M #2

ONCSQ

OncoSec Medical Incorporated

40$0M #3

NBSE

NeuBase Therapeutics, Inc.YOU

37$1M #4

ASLN

ASLAN Pharmaceuticals Limited

35$777M #5

CYTO

Altamira Therapeutics Ltd.

10$1M #6

NMTRQ

9 Meters Biopharma, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NBSE peer comparison

About NBSE employees

NBSE Employees · Headcount

NeuBase Therapeutics, Inc. (NBSE) employee data is sourced from the annual SEC 10-K filing. As of 2022, NeuBase Therapeutics, Inc. had 37 full-time employees globally. Full-time employees only. Global consolidated headcount.

NeuBase Therapeutics, Inc.'s workforce increased by 4 (12.12%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NBSE Employees · 5 questions

As of the latest SEC 10-K filing (2022), NeuBase Therapeutics, Inc. had 37 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NeuBase Therapeutics, Inc. employee counthow many employees does NeuBase Therapeutics, Inc. haveNBSE total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2022-12-21